Stocks and InvestingStocks and Investing
Fri, September 22, 2023
Thu, September 21, 2023
Wed, September 20, 2023
Tue, September 19, 2023

Raghuram Selvaraju Reiterated (ACRS) at Strong Buy and Held Target at $43 on, Sep 19th, 2023


Published on 2024-10-28 06:28:36 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy and Held Target at $43 on, Sep 19th, 2023.

Raghuram has made no other calls on ACRS in the last 4 months.



There is 1 other peer that has a rating on ACRS. Out of the 1 peers that are also analyzing ACRS, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Alex Thompson of "Stifel" Maintained at Strong Buy with Increased Target to $20 on, Thursday, September 14th, 2023